In an extensive analysis of 110 consecutive patients with a confirmed diagnosis of ACC between the years 1990 and 2017, PSMA expression was explored, and survival was analyzed using multivariate Cox-proportional hazard analysis; PSMA was found to be expressed in primary, recurrent, and metastatic ACC of both the salivary and seromucous glands [180]. This evidence concerns the gene FOLH1 and adrenal cortex carcinoma.